Skip to content

Dysphagia After Different Swallowing Therapies

Acute Stroke Patients With Dysphagia After Different Swallowing Therapies: Videofluoroscopy Findings and Brain Plasticity in Magnetic Resonance Imaging

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03048916
Enrollment
58
Registered
2017-02-09
Start date
2010-08-01
Completion date
2013-07-31
Last updated
2017-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dysphagia, Stroke, Videofluoroscopy

Keywords

dysphagia, stroke, magnetic resonance imaging, videofluoroscopy

Brief summary

Dysphagia after stroke is associated to increased pulmonary complications and mortality. The swallowing therapies could decrease the pulmonary complications and improve the quality of life after stroke. The swallowing therapies include dietary modifications, thermal stimulation, compensatory positions, and oropharyngeal muscle stimulation. Most researchers used clinical assessments and videofluoroscopy to evaluate the effect of the swallowing therapies. Some authors performed functional magnetic resonance imaging (fMRI) to investigate the brain neuroactivity during swallowing with tasks in normal adults and unilateral hemispheric stroke patients. The aim of this study is to explore the effect of swallowing therapies not only in clinical swallowing function but also brain plasticity of acute stroke patients with dysphagia by videofluoroscopy and fMRI.

Detailed description

In the study, 10 healthy controls and 48 patients with a single and acute hemispheric or brain stem stroke will be enrolled. Both 24 hemispheric and 24 brain stem stroke patients will be divided into 3 groups. General swallowing therapy, oropharyngeal neuromuscular electrical stimulation (NMES), and combined general and NMES therapies will be randomly provided for the 3 groups. Each patient will receive clinical assessment of food oral intake scale, functional dysphagia scale of videofluoroscopy, and brain neuroactivity in fMRI. The investigators hope to find the benefit of the swallowing therapies both in clinical swallowing function and in brain functional neuroactivity/reorganization after acute stroke. While comparing the 3 swallowing therapies, different functional neuroactivity may be facilitated by different swallowing therapies. Finally, the investigators could also find out the most effective swallowing therapy among the 3 therapies in acute stroke patients with dysphagia according to the findings of videofluoroscopy and fMRI.

Interventions

OTHERgeneral swallowing therapy

including a session of oral exercises, tactile stimulation, compensatory techniques, swallowing maneuvers that are taught to the participants by a speech therapist.

OTHERNMES therapy

he NMES therapy with VitalStim therapeutic device will be done by one physician who is licensed practitioner and certified in use of the VitalStim device. The placement of 2-channel electrodes is depended on the dysphagic types and the findings on VFS.

Sponsors

Chang Gung Memorial Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

of normal controls: * normal neurological examination * no history of stroke * no active neurological disorder Inclusion criteria of hemispheric stroke patients: * a single cerebral hemispheric stroke * swallowing difficulty: detected by bedside swallow assessment by a physician while admitting to the rehabilitation unit. Inclusion criteria of these brain stem stroke patients: * a single brain stem stroke without prior stroke history * swallowing difficulties: detected by bedside swallow assessment by a physician while admitting to the rehabilitation unit

Exclusion criteria

* multiple brain lesions due to one episode of stroke * impaired communication ability due to cognition deficit * other central or peripheral neurological deficit leading to swallowing difficulty. * use of an electrically sensitive biomedical device (eg. cardiac pacemaker) * metal clip in the brain * pneumonia at the time of enrollment.

Design outcomes

Primary

MeasureTime frameDescription
The functional oral intake scalebaseline (before intervention), changes from baseline FOIS at 4 weeksClinical swallowing evaluations: The functional oral intake scale (FOIS) was reported by Crary et al. for presenting the functional oral intake of food and liquid in stroke patients. One physician who is blinded to the therapies will evaluate the FOIS for each participant before and after swallowing treatments.

Secondary

MeasureTime frameDescription
8-point penetration-aspiration scale (PAS)baseline (before intervention), changes from baseline PAS score at 4 weeksVFS is a standard tool for swallowing disorders. A 8-point penetration-aspiration scale (PAS) is used for observing the event of penetration or aspiration on VFS.
11-item functional dysphagia scale (FDS)baseline (before intervention), changes from baseline FDS score at 4weeksA 11-item functional dysphagia scale (FDS) of VFS is a sensitive and specific method for quantifying swallowing function in stroke.
3-Dimensional (3D) structural MRIbaseline (before intervention), changes from baseline result of 3-Dimensional (3D) structural MRI at 4 weeksMR images are obtained using a 3.0-T whole body magnet with a 50- and 23-mT/m gradient strength, and an echo-planar-capable receiver (GE SIGNA EXCITE HD, GE Medical Systems, Milwaukee, US). A 3-dimensional (3D) structural MRI is acquired for each subject using a T1-weighted gradient echo magnetization prepared rapid gradient echo sequence yielding 124 sagittal slices with a defined voxel size of 1 x 1 x 1.5 mm.
Function MRIbaseline (before intervention), changes from baseline result of fMRI at 4 weeksMR images are obtained using a 3.0-T whole body magnet with a 50- and 23-mT/m gradient strength, and an echo-planar-capable receiver (GE SIGNA EXCITE HD, GE Medical Systems, Milwaukee, US). The functional images are obtained using an EPI sequence with the following parameters: 33 axial slices, image resolution = 3.75\*3.75\*4, and TR= 2000 ms.
Diffusion tensor imagingbaseline (before intervention), changes from baseline result of diffusion tensor imaging at 4 weeksMR images are obtained using a 3.0-T whole body magnet with a 50- and 23-mT/m gradient strength, and an echo-planar-capable receiver (GE SIGNA EXCITE HD, GE Medical Systems, Milwaukee, US). An 8 channels diffusion tensor imaging (DTI) acquisition protocol will be used to acquire high resolution DTI, i.e. 2 x 2 x 2 mm3 voxel size. With 13 diffusion encoding directions and number of average of 4, whole brain DTI and high resolution eigenvector field can be acquired within 20 mins.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026